# AVITA Medical (RCEL) — Earnings

RCEL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rcel/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.25 |
| EPS estimate | −$0.29 |
| EPS surprise | +14.62% |
| Revenue surprise | +6.12% |
| Revenue | $21.5M |
| Revenue estimate | $20.3M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1762303/000119312526338101/rcel-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/26ce35f1-e978-7e55-df63-30ae4340a7f0.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.29 | −$0.25 | 14.62% | $20.3M | $21.5M |
| Q1 2026 | May 14, 2026 | −$0.29 | −$0.35 | -19.86% | $18.3M | $19.3M |
| Q4 2025 | Feb 12, 2026 | −$0.36 | −$0.38 | -4.28% | $17.8M | $17.4M |
| Q3 2025 | Nov 6, 2025 | −$0.33 | −$0.46 | -38.60% | $18.4M | $17.1M |
| Q2 2025 | Aug 7, 2025 | −$0.25 | −$0.38 | -52.00% | $22.5M | $18.4M |
| Q1 2025 | May 8, 2025 | −$0.32 | −$0.53 | -64.04% | $20.8M | $18.5M |
| Q4 2024 | Feb 13, 2025 | −$0.45 | −$0.44 | 1.50% | $20.7M | $18.2M |
| Q3 2024 | Nov 7, 2024 | −$0.45 | −$0.62 | -38.67% | $19.4M | $19.5M |
| Q2 2024 | Aug 8, 2024 | −$0.50 | −$0.60 | -20.89% | $14.5M | $15.2M |
| Q1 2024 | May 13, 2024 | −$0.48 | −$0.73 | -52.62% | $11.1M | $11.1M |
| Q4 2023 | Feb 22, 2024 | −$0.39 | −$0.28 | 28.99% | $14.2M | $14.2M |
| Q3 2023 | Nov 9, 2023 | −$0.44 | −$0.34 | 21.89% | $13.4M | $13.6M |
| Q2 2023 | Aug 10, 2023 | −$0.31 | −$0.41 | -30.91% | $11.3M | $11.8M |
| Q1 2023 | May 11, 2023 | −$0.27 | −$0.37 | -36.94% | $10.3M | $10.6M |
| Q4 2022 | Feb 23, 2023 | −$0.24 | −$0.21 | 13.26% | $8.8M | $9.5M |
| Q3 2022 | Nov 10, 2022 | −$0.33 | −$0.22 | 33.57% | $7.5M | $9.1M |
| Q2 2022 | Aug 11, 2022 | −$0.34 | −$0.25 | 27.16% | $7.3M | $8.3M |
| Q4 2021 | Feb 28, 2022 | −$0.29 | −$0.19 | 34.93% | $8.3M | $10.3M |
| Q1 2022 | May 12, 2022 | −$0.35 | −$0.38 | -9.10% | $7.2M | $7.5M |
| Q3 2021 | May 13, 2021 | −$0.35 | −$0.26 | 25.74% | $7.3M | $8.8M |

## Frequently Asked Questions

### When did AVITA Medical (RCEL) last report earnings?

AVITA Medical last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did RCEL beat earnings estimates?

Yes. AVITA Medical reported EPS of −$0.25 for Q2 2026 against a −$0.29 estimate — a 14.62% beat.

### How much revenue did RCEL report last quarter?

AVITA Medical reported $21.5M in revenue for Q2 2026, against a consensus estimate of $20.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).